Mayne Pharma Group FY23 Results 2023

Mayne Pharma Group Limited's FY23 results presentation covering financial performance, strategic transformation including the acquisition of women's health products from TherapeuticsMD, divestment of non-core assets, and improved profitability across all business segments in the second half of FY23.